A Phase I/II Study of Eltrombopag in Elderly Patients With AML.

Trial Profile

A Phase I/II Study of Eltrombopag in Elderly Patients With AML.

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 21 Jul 2016

At a glance

  • Drugs Eltrombopag (Primary)
  • Indications Acute myeloid leukaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Jul 2016 Status changed from completed to active, no longer recruiting.
    • 11 Oct 2012 Status changed from completed to recruiting as reported by ClinicalTrials.gov.
    • 17 May 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top